RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes.
glaucoma
myopia
pattern electroretinogram
perg
re-perg
steady-state
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
04
2019
accepted:
21
06
2019
entrez:
24
8
2019
pubmed:
24
8
2019
medline:
24
8
2019
Statut:
epublish
Résumé
To evaluate reliability of steady-state pattern electroretinogram (ssPERG) phase variability in re-test (procedure called RE-PERG) in the presence of myopia, which is known to affect ssPERG amplitude, in glaucomatous patients (GP), normal controls (NC), and myopic patients (MY). The procedure was performed on 50 GP, 35 NC, and 19 MY. All subjects were examined with RE-PERG, spectral-domain coherence tomography (SD-OCT), and standard automated perimetry (SAP). Standard deviation of phase (ssPERG SDph) and mean amplitude value (ssPERG Amp) of second harmonic (2ndH) were correlated, by means of one-way ANOVA and Pearson correlation, with mean deviation (MD) and pattern standard deviation (PSD) assessed by SAP and retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) thickness assessed by SD-OCT. Receiving operating characteristics were calculated in cohort populations with and without myopia. GP showed significant differences from the control group for MD, PSD, RNFL, GCC, ssPERG Amp, and ssPERG SDph; GP also showed significant differences from the MY group for all the parameters except for ssPERG Amp, which is reduced in both groups. In GP group, ssPERG Amp showed a specificity of 82.1% (95% confidence interval [CI]I: 66.5-92.5). In MY group, ssPERG Amp was reduced in 58% of the patients. As a consequence of this, in GP and MY groups, considered as a whole, total specificity dropped to 70.69% (95% CI: 57.3-81.9). In the GP group, ssPERG SDph showed a specificity of 84.6% (95% CI: 69.5-91.1). In both GP and MY groups, considered as a whole, ssPERG SDph total specificity increased from 84.6% to 93.1% (95% CI: 83.3-98.1). Intrinsic phase variability of ssPERG is not influenced by myopia, even in the presence of fundus alterations.
Identifiants
pubmed: 31440021
doi: 10.2147/OPTH.S211337
pii: 211337
pmc: PMC6664252
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1315-1322Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Ger J Ophthalmol. 1992;1(1):35-40
pubmed: 1477616
Ophthalmology. 2005 Jan;112(1):10-9
pubmed: 15629814
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1296-302
pubmed: 15790894
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3904-11
pubmed: 16936103
Optom Vis Sci. 2008 Jun;85(6):386-95
pubmed: 18521020
Ophthalmology. 2009 Mar;116(3):437-43
pubmed: 19167080
J Glaucoma. 2010 Apr-May;19(4):243-7
pubmed: 19528818
Eye Contact Lens. 2009 Sep;35(5):238-41
pubmed: 19672200
J Glaucoma. 2009 Aug;18(6):437-42
pubmed: 19680050
Am J Ophthalmol. 2010 Mar;149(3):488-95
pubmed: 20172073
Br J Ophthalmol. 2011 Aug;95(8):1115-21
pubmed: 20805125
Arch Ophthalmol. 2010 Sep;128(9):1129-35
pubmed: 20837795
Eye (Lond). 2011 Feb;25(2):224-32
pubmed: 21183943
Br J Ophthalmol. 2012 Jan;96(1):57-61
pubmed: 21349942
Ophthalmology. 2011 Sep;118(9):1774-81
pubmed: 21550120
Graefes Arch Clin Exp Ophthalmol. 2012 Dec;250(12):1843-9
pubmed: 22555896
J Clin Diagn Res. 2015 Feb;9(2):NC01-3
pubmed: 25859476
Biomed Res Int. 2015;2015:571314
pubmed: 26167489
PLoS One. 2015 Nov 06;10(11):e0142383
pubmed: 26544553
Semin Ophthalmol. 2017;32(6):682-688
pubmed: 27404600
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4910-4915
pubmed: 27654417
Korean J Ophthalmol. 2016 Oct;30(5):335-343
pubmed: 27729753
Clin Exp Optom. 2017 Nov;100(6):690-694
pubmed: 28125859
Clin Ophthalmol. 2017 Jan 23;11:209-218
pubmed: 28176965
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Science. 1981 Feb 27;211(4485):953-5
pubmed: 7466369
Clin Electroencephalogr. 1997 Jul;28(3):143-7
pubmed: 9241467
Acta Ophthalmol Scand Suppl. 1997;(224):30-1
pubmed: 9589721